Aigen Investment Management’s GoodRx Holdings GDRX Stock Holding History

Aigen Investment Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,658	Closed	-$103K	–	900
2025 Q2	$103K	Sell	20,658 -8,726	-30%	-$37.9K	0.01%	720
2025 Q1	$130K	Buy	29,384 +16,052	+120%	+$75.3K	0.02%	667
2024 Q4	$62K	Buy	+13,332	New	+$73.3K	0.01%	690
2024 Q3	–	Sell	-31,071	Closed	-$242K	–	829
2024 Q2	$242K	Buy	31,071 +16,381	+112%	+$121K	0.05%	561
2024 Q1	$104K	Buy	+14,690	New	+$97.2K	0.02%	610
2023 Q3	–	Sell	-31,497	Closed	-$174K	–	924
2023 Q2	$174K	Buy	+31,497	New	+$170K	0.03%	643
2022 Q4	–	Sell	-15,950	Closed	-$74K	–	626
2022 Q3	$74K	Buy	+15,950	New	+$101K	0.01%	556

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aigen Investment Management's GDRX Position: Q3 2025 in Review

Aigen Investment Management sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 20,658 shares — an estimated $103K sold.

Aigen Investment Management first reported a position in GDRX in Q3 2022 and held it in 7 quarters. The position peaked at $242K in Q2 2024. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

Aigen Investment Management reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
Aigen Investment Management sold 20,658 GoodRx Holdings shares in Q3 2025, an estimated $103K.
Aigen Investment Management first reported a position in GoodRx Holdings in Q3 2022 and held it in 7 quarters.
Aigen Investment Management's GoodRx Holdings position peaked at $242K in Q2 2024.
161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.